Canlyniadau Chwilio - Anne‐Marie C. Dingemans

Mireinio'r Canlyniadau
  1. 1
    Heat shock protein antagonists in early stage clinical trials for NSCLC

    Heat shock protein antagonists in early stage clinical trials for NSCLC gan Lizza Hendriks, Anne‐Marie C. Dingemans

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm

    Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm gan Thierry Berghmans, Anne‐Marie C. Dingemans, Lizza Hendriks, J. Cadranel

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Immunotherapy: From Advanced NSCLC to Early Stages, an Evolving Concept

    Immunotherapy: From Advanced NSCLC to Early Stages, an Evolving Concept gan Thierry Berghmans, Valérie Durieux, Lizza Hendriks, Anne‐Marie C. Dingemans

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Response Assessment Using <sup>18</sup>F-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non–Small Cell Lung Cancer

    Response Assessment Using <sup>18</sup>F-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non–Small Cell Lung Cancer gan Wouter van Elmpt, Michel Öllers, Anne‐Marie C. Dingemans, Philippe Lambin, Dirk De Ruysscher

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer

    MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer gan Jih‐Hsiang Lee, Johannes Voortman, Anne‐Marie C. Dingemans, Donna Voeller, Trung C. Pham, Yisong Wang, Giuseppe Giaccone

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Management of stage I and II nonsmall cell lung cancer

    Management of stage I and II nonsmall cell lung cancer gan Fiona McDonald, Michèle De Waele, Lizza Hendriks, Corinne Faivre‐Finn, Anne‐Marie C. Dingemans, Paul Van Schil

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management

    New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management gan Jules L. Derks, Noémie Leblay, Sylvie Lantuéjoul, Anne‐Marie C. Dingemans, Ernst‐Jan M. Speel, Lynnette Fernández-Cuesta

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients with Non–Small Cell Lung Cancer and Bone Metastases: A Systematic Review

    Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients with Non–Small Cell Lung Cancer and Bone Metastases: A Systematic Review gan Lizza Hendriks, B.C.M. Hermans, M.H.J. van den Beuken-van Everdingen, Monique Hochstenbag, Anne‐Marie C. Dingemans

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    [18F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients

    [18F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients gan Steven Petit, Wouter J. C. van Elmpt, Cary Oberije, Erik Vegt, Anne‐Marie C. Dingemans, Philippe Lambin, André Dekker, Dirk De Ruysscher

    Cyhoeddwyd 2010
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer

    Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer gan Anne‐Marie C. Dingemans, Vivian van den Boogaart, Bettine A.H. Vosse, Robert‐Jan van Suylen, Arjan W. Griffioen, Victor L. Thijssen

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC

    Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC gan Karin J.C. Sanders, Lizza Hendriks, Esther G.C. Troost, Gerben Bootsma, Ruud Houben, Annemie M.W.J. Schols, Anne‐Marie C. Dingemans

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Defining Synchronous Oligometastatic Non–Small Cell Lung Cancer: A Systematic Review

    Defining Synchronous Oligometastatic Non–Small Cell Lung Cancer: A Systematic Review gan Niccolò Giaj-Levra, Matteo Giaj Levra, Valérie Durieux, Silvia Novello, Benjamin Besse, Baktiar Hasan, Lizza Hendriks, Antonin Lévy, Anne‐Marie C. Dingemans, Thierry Berghmans

    Cyhoeddwyd 2019
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study

    Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study gan Lizza Hendriks, Jules L. Derks, Pieter E. Postmus, Ronald Damhuis, Ruud Houben, Esther G.C. Troost, M. Hochstenbag, Egbert F. Smit, Anne‐Marie C. Dingemans

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

    Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? gan Joline S.W. Lind, Martijn R. Meijerink, Anne‐Marie C. Dingemans, Cornelis van Kuijk, Michel Öllers, Dirk De Ruysscher, Pieter E. Postmus, Egbert F. Smit

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450)

    Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450) gan Dirk De Ruysscher, Rinus Wanders, Lizza Hendriks, Angela van Baardwijk, Bart Reymen, Ruud Houben, Gerben Bootsma, Cordula Pitz, Linda van Eijsden, Anne‐Marie C. Dingemans

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia

    Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia gan Celine M. Op den Kamp, Ramon Langen, Frank J. M. Snepvangers, Chiel C. de Theije, Johanna M Schellekens, Fabian Laugs, Anne‐Marie C. Dingemans, Annemie Schols

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non–Small-Cell Lung Cancer

    Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non–Small-Cell Lung Cancer gan Angela van Baardwijk, S. Wanders, Liesbeth Boersma, Jacques Borger, Michel Öllers, Anne‐Marie C. Dingemans, Gerben Bootsma, Wiel Geraedts, Cordula Pitz, Ragnar Lunde, Philippe Lambin, Dirk De Ruysscher

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens?

    Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens? gan Jules L. Derks, Anne‐Marie C. Dingemans, Robert‐Jan van Suylen, Michael A. den Bakker, Ronald Damhuis, Esther C. van den Broek, Ernst‐Jan Speel, Erik Thunnissen

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Handgrip weakness, low fat‐free mass, and overall survival in non‐small cell lung cancer treated with curative‐intent radiotherapy

    Handgrip weakness, low fat‐free mass, and overall survival in non‐small cell lung cancer treated with curative‐intent radiotherapy gan Chris Burtin, Jacques Bezuidenhout, Karin J.C. Sanders, Anne‐Marie C. Dingemans, Annemie M.W.J. Schols, Stéphanie Peeters, Martijn A. Spruit, Dirk K.M. De Ruysscher

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Pre-cachexia in patients with stages I–III non-small cell lung cancer: Systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system

    Pre-cachexia in patients with stages I–III non-small cell lung cancer: Systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome sy... gan Celine M. Op den Kamp, Ramon Langen, Ronnie Minnaard, Marco Kelders, Frank J. M. Snepvangers, M. K.C. Hesselink, Anne‐Marie C. Dingemans, Annemie M.W.J. Schols

    Cyhoeddwyd 2011
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: